SymBio Pharmaceuticals Limited

SYMQY · OTC
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$23,454$3,053,848$3,614,766$3,963,000
Short-Term Investments$0$0$0$0
Receivables$1,325$205,021$211,660$423,000
Inventory$2,240$274,900$256,580$238,000
Other Curr. Assets$480$54,020$101,470$190,000
Total Curr. Assets$30,714$4,096,035$4,628,063$4,924,000
Property Plant & Equip (Net)$0$37,349$37,349$0
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$38,000$15$44,000
Tax Assets$45$5,678$1,852$0
Other NC Assets$253-$37,985$0$0
Total NC Assets$298$43,042$39,216$44,000
Other Assets$0$2$2$0
Total Assets$31,013$4,139,079$4,667,281$4,968,000
Liabilities
Payables$0$0$0$0
Short-Term Debt$0$0$0$0
Tax Payable$0$99,462$62,151$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$3,574$32,066$49,606$28,142
Total Curr. Liab.$3,946$470,228$564,561$766,000
LT Debt$15,845$1,300,000$700,000$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$33$4,847$4,594$7,000
Total NC Liab.$15,877$1,304,847$704,594$7,000
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$19,823$1,775,075$1,269,155$773,000
Equity
Pref Stock$0$0$0$0
Common Stock$127,601$18,598,304$18,588,044$18,336,000
Retained Earnings-$245,465-$35,054,974-$34,006,782-$32,685,000
AOCI$2,231$0$343,815$322,000
Other Equity$0$337,374$0$0
Total Equity$11,189$2,364,004$3,398,126$4,195,000
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$31,013$4,139,079$4,667,281$4,968,000
Net Debt-$7,609-$1,753,848-$2,914,766-$3,963,000